79 reports

  • HEART FAILURE DRUGS MARKET IN APAC
  • HEART FAILURE DRUGS MARKET IN EMEA

FACTORS CAUSING HEART FAILURE Heart failure can affect one or both the sides of the heart.

  • Beta-Blocker
  • Heart Failure
  • Amgen Inc.
  • AstraZeneca PLC
  • Novartis AG
  • HEART FAILURE THERAPEUTICS MARKET, SYMPTOMS
  • HEART FAILURE THERAPEUTICS MARKET, ETIOLOGIES OF HF

HEART FAILURE; ##(##): ##-## FIQUEROA MS AND PETERS JI (2006).

  • Heart Failure
  • Market Size
  • Bristol-Myers Squibb Company
  • Les Laboratoires Servier SAS
  • Novartis AG

MARKET ##.

  • Heart Failure
  • Europe
  • Japan
  • United States
  • World
  • 2 Heart Failure: Executive Summary
  • 4.1 BIBLIOGRAPHY

Heart Failure.

  • Heart Failure
  • Hospital
  • United States
  • Forecast
  • American Heart Association, Inc.

Heart failure software Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024 ##.

  • Chronic Disease
  • Heart Failure
  • Pathology
  • World
  • Market Size

2019 Diastolic Heart Failure Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 ##.

  • Chronic Disease
  • Clinical Trial
  • Drug Development
  • Heart Failure
  • Pharmaceutical

Global Acute Heart Failure Epidemiology and Patient Flow Analysis - 2017 ##.

  • Heart Failure
  • France
  • United States
  • World
  • Forecast
  • NYHA Classification of Heart Failure
  • Aetiologies of Heart Failure

ONE-YEAR MORTALITY AMONG UNSELECTED OUTPATIENTS WITH HEART FAILURE.

  • Cardiovascular Disease
  • Chronic Disease
  • Heart Failure
  • Pathology

Europe Acute Heart Failure Epidemiology and Patient Flow Analysis - 2017 ##.

  • Heart Failure
  • Europe
  • France
  • Germany
  • Italy
  • 4.2.7 THE US HEART FAILURE INJECTAFER IV IRON DRUGS MARKET BY VALUE
  • 4.3.5 THE US HEART FAILURE IV IRON DRUGS MARKET BY VALUE

Heart Failure: Heart failure occurs when heart muscle is unable to pump blood as it should.

  • Heart Failure
  • United States
  • World
  • AMAG Pharmaceuticals, Inc.
  • Daiichi Sankyo Company
  • Acquisitions
  • MEDTRONIC: COMPANY SNAPSHOT (2016)

According to the International Congestive Heart Failure Study, India has one of the highest mortality rates in heart failure patients-##% of heart failure patients die within a year of diagnosis.

  • Heart Failure
  • North America
  • United States
  • Abiomed, Inc.
  • Impella CardioSystems AG
  • 12.8.5 BUSINESS STRATEGY
  • APPROVALS, (2015-2017)

PHASE ## HEART FAILURE TAH/ BVAD PRECLINICAL BIVACOR, INC.

  • Heart Failure
  • World
  • Market Size
  • Abiomed, Inc.
  • Medtronic, Inc.
  • 11.7.4 KEY DEVELOPMENTS
  • By Patient Type

IN 2009, ## IN ## DEATHS IN THE US INCLUDED HEART FAILURE AS CONTRIBUTING CAUSE.

  • Heart Failure
  • World
  • Market Size
  • Abbott Laboratories, Inc.
  • Abiomed, Inc.
  • SAPIEN 3 HEART VALVE - HEART FAILURE
  • SAPIEN 3 HEART VALVE - HEART FAILURE - PRODUCT STATUS

## Heart Failure ## Hemodynamic Instability ## Hypotension ## Pulmonary Valve Disease ## Right Ventricular Outflow Tract Stenosis ## Tricuspid Regurgitation ## Indication No of Products BUSINESS DESCRIPTION Edwards Lifescience

  • Heart Failure
  • Prosthesis
  • United States
  • Edwards Lifesciences Corporation
  • Valtech Cardio, Ltd.
  • 2.1 HEART FAILURE: AN OVERVIEW
  • TREATMENT ALTERNATIVES FOR HEART FAILURE

The body also tries to compensate in other ways: ##. ##. ## Treatment Alternatives for Heart Failure ##. ## HEART FAILURE: AN OVERVIEW FIGURE ##: TREATMENT ALTERNATIVES FOR HEART FAILURE Medical Management Coronary Angioplasty Coronary Artery Byp

  • Heart Failure
  • HeartWare International, Inc.
  • Jude Medical, Inc.
  • ReliantHeart
  • Thoratec Corporation
  • FOCUS ON UNMET NEEDS FOR ADVANCED HEART FAILURE
  • HOSPITAL ADMISSION FOR CONGESTIVE HEART FAILURE PER 100,000 INDIVIDUALS IN FEW COUNTRIES IN EMEA 2008 AND 2013

Low ## Future scenario (2020) ## ## ## ## High However, a limited number of heart donors are present compared with people with heart failure.

  • Heart Failure
  • Abiomed, Inc.
  • HeartWare International, Inc.
  • Jude Medical, Inc.
  • Thoratec Corporation

Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H##, 2019 List of Tables List of Figures Report Guidance GlobalData Clinical Trials Report Coverage Clinical Trials by Region Clinical Trials and Average Enrollment by Country Clinical Trials b

  • Cardiovascular Disease
  • Chronic Disease
  • Clinical Trial
  • Heart Failure
  • World
  • PROPORTION OF DIASTOLIC HEART FAILURE TO CARDIOVASCULAR CLINICAL TRIALS, G7 COUNTRIES (%), 2019*
  • DIASTOLIC HEART FAILURE THERAPEUTICS, GLOBAL, CLINICAL TRIALS BY PHASE (%), 2019*

CLINICAL TRIALS BY PHASE IN G## COUNTRIES DIASTOLIC HEART FAILURE THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2019* DIASTOLIC HEART FAILURE THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2019* DIASTOLIC HEART FAILURE THERAPEUTICS,

  • Clinical Trial
  • Heart Failure
  • Therapy
  • World
  • Product Initiative
  • ACUTE HEART FAILURE THERAPEUTICS, G7 COUNTRIES, CLINICAL TRIALS BY TRIAL STATUS, 2018*
  • ACUTE HEART FAILURE THERAPEUTICS CLINICAL TRIALS, GLOBAL, KEY SPONSORS, 2018*

CLINICAL TRIALS BY PHASE IN E## COUNTRIES ACUTE HEART FAILURE THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2018* ACUTE HEART FAILURE THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2018* Country Name Phase IV Phase III/ IV Phase III Phase II/

  • Cardiology
  • Heart Failure
  • World
  • Product Initiative
  • Novartis AG
  • SYSTOLIC HEART FAILURE THERAPEUTICS, G7 COUNTRIES, CLINICAL TRIALS BY TRIAL STATUS, 2018*
  • SYSTOLIC HEART FAILURE THERAPEUTICS, GLOBAL, CLINICAL TRIALS BY REGION (%), 2018*

SYSTOLIC HEART FAILURE THERAPEUTICS CLINICAL TRIALS, GLOBAL, BY END POINT STATUS, 2018* CLINICAL TRIALS BY END POINT STATUS SYSTOLIC HEART FAILURE THERAPEUTICS CLINICAL TRIALS, GLOBAL, BY END POINT STATUS, 2018* SYSTOLIC HEART FAILURE THERAPEUTIC

  • Clinical Trial
  • Heart Failure
  • Therapy
  • World
  • Product Initiative
  • CONGESTIVE HEART FAILURE (HEART FAILURE)
  • CONGESTIVE HEART FAILURE (HEART FAILURE)

HEART FAILURE GENE THERAPY TO ACTIVATE PSEN## FOR HEART FAILURE GENE THERAPY TO ACTIVATE UCN ## FOR CONGESTIVE HEART FAILURE GENE THERAPY TO TARGET MAKAPBETA FOR HEART FAILURE HEARTCEL ASCELEGEN THERAPEUTICS INC TENAYA THERAPEUTIC

  • Heart Failure
  • Regenerative Medicine
  • North America
  • United States
  • Company
  • CONGESTIVE HEART FAILURE (HEART FAILURE)
  • CONGESTIVE HEART FAILURE (HEART FAILURE)

Co., Ltd. registered a Phase III trial of rhNRG-## to evaluate efficacy of rhNRG-## in reducing the death rate of heart failure.

  • Cardiovascular Disease
  • Chronic Disease
  • Heart Failure
  • United States
  • Product Initiative
  • DIASTOLIC HEART FAILURE THERAPEUTICS, GLOBAL, CLINICAL TRIALS BY REGION (%), 2017*
  • DIASTOLIC HEART FAILURE THERAPEUTICS, G7 COUNTRIES, CLINICAL TRIALS BY TRIAL STATUS, 2017*

CLINICAL TRIALS BY PHASE IN G## COUNTRIES DIASTOLIC HEART FAILURE THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2017* DIASTOLIC HEART FAILURE THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2017* DIASTOLIC HEART FAILURE THERAPEUTICS,

  • Heart Failure
  • Therapy
  • World
  • Product Initiative
  • Pfizer Inc.

Systolic Heart Failure Ongoing Global Clinical Trials Analysis and Outlook ## Table of Contents ##. ## List of Figures ##. ## List of Tables ## Key Findings, 2018 ##. ## Snapshot ##. ## Overview of Systolic Heart Failure Trials ## Clinical Trials Trends to 2022 ##. ## Ongo

  • Chronic Disease
  • Clinical Trial
  • Drug Development
  • Heart Failure

Diastolic Heart Failure Ongoing Global Clinical Trials Analysis and Outlook ## Table of Contents ##. ## List of Figures ##. ## List of Tables ## Key Findings, 2018 ##. ## Snapshot ##. ## Overview of Diastolic Heart Failure Trials ## Clinical Trials Trends to 2022 ##. ## On

  • Chronic Disease
  • Clinical Trial
  • Drug Development
  • Heart Failure

Acute Heart Failure Ongoing Global Clinical Trials Analysis and Outlook ## Table of Contents ##. ## List of Figures ##. ## List of Tables ## Key Findings, 2018 ##. ## Snapshot ##. ## Overview of Acute Heart Failure Trials ## Clinical Trials Trends to 2022 ##. ## Ongoing Ac

  • Chronic Disease
  • Clinical Trial
  • Drug Development
  • Heart Failure

Insights into Acute Heart Failure Pipeline ##.

  • Chronic Disease
  • Heart Failure
  • World
  • REVENUE OF GLOBAL BTR THERAPY IN LVAD MARKET 2015-2020 ($ MILLIONS)
  • Acquisition

OPEN HEART SURGERY IS ONE OF THE MOST EXPENSIVE MEDICAL PROCEDURES.

  • Heart Failure
  • World
  • Abiomed, Inc.
  • Jarvik Heart, Inc.
  • Jude Medical, Inc.
  • Latest Clinical Trials News on Acute Heart Failure
  • ACUTE HEART FAILURE THERAPEUTICS, GLOBAL, CLINICAL TRIALS BY PHASE (%), 2017*

ACUTE HEART FAILURE THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2017* Clinical Trials by Phase in E## Countries ACUTE HEART FAILURE THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2017* ACUTE HEART FAILURE THERAPEUTICS, E## COUNTRIE

  • Clinical Trial
  • Heart Failure
  • World
  • Product Initiative
  • Novartis AG

2019 Congestive Heart Failure/ Heart Failure Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets ##.

  • Cardiovascular Disease
  • Chronic Disease
  • Heart Failure
  • Pathology
  • APAC